View Item 

Show simple item record

Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverterâ Defibrillators in the Cardiovascular Research Network
dc.contributor.authorGreenlee, Robert T.
dc.contributor.authorGo, Alan S.
dc.contributor.authorPeterson, Pamela N.
dc.contributor.authorCassidy‐bushrow, Andrea E.
dc.contributor.authorGaber, Charles
dc.contributor.authorGarcia‐montilla, Romel
dc.contributor.authorGlenn, Karen A.
dc.contributor.authorGupta, Nigel
dc.contributor.authorGurwitz, Jerry H.
dc.contributor.authorHammill, Stephen C.
dc.contributor.authorHayes, John J.
dc.contributor.authorKadish, Alan
dc.contributor.authorMagid, David J.
dc.contributor.authorMcManus, David D.
dc.contributor.authorMulterer, Deborah
dc.contributor.authorPowers, J. David
dc.contributor.authorReifler, Liza M.
dc.contributor.authorReynolds, Kristi
dc.contributor.authorSchuger, Claudio
dc.contributor.authorSharma, Param P.
dc.contributor.authorSmith, David H.
dc.contributor.authorSuits, Mary
dc.contributor.authorSung, Sue Hee
dc.contributor.authorVarosy, Paul D.
dc.contributor.authorVidaillet, Humberto J.
dc.contributor.authorMasoudi, Frederick A.
dc.date.accessioned2018-05-15T20:14:53Z
dc.date.available2019-06-03T15:24:19Zen
dc.date.issued2018-04-03
dc.identifier.citationGreenlee, Robert T.; Go, Alan S.; Peterson, Pamela N.; Cassidy‐bushrow, Andrea E. ; Gaber, Charles; Garcia‐montilla, Romel ; Glenn, Karen A.; Gupta, Nigel; Gurwitz, Jerry H.; Hammill, Stephen C.; Hayes, John J.; Kadish, Alan; Magid, David J.; McManus, David D.; Multerer, Deborah; Powers, J. David; Reifler, Liza M.; Reynolds, Kristi; Schuger, Claudio; Sharma, Param P.; Smith, David H.; Suits, Mary; Sung, Sue Hee; Varosy, Paul D.; Vidaillet, Humberto J.; Masoudi, Frederick A. (2018). "Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverterâ Defibrillators in the Cardiovascular Research Network." Journal of the American Heart Association (7): n/a-n/a.
dc.identifier.issn2047-9980
dc.identifier.issn2047-9980
dc.identifier.urihttps://hdl.handle.net/2027.42/143721
dc.publisherWiley Interscience
dc.subject.othersudden cardiac death
dc.subject.otherimplantable cardioverterâ defibrillator
dc.subject.otherarrhythmia
dc.subject.otherinappropriate shock
dc.subject.otheroutcomes research
dc.titleDevice Therapies Among Patients Receiving Primary Prevention Implantable Cardioverterâ Defibrillators in the Cardiovascular Research Network
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelCardiovascular Medicine
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/143721/1/jah33061_am.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/143721/2/jah33061.pdf
dc.identifier.sourceJournal of the American Heart Association
dc.identifier.citedreferenceSchwab JO, Bonnemeier H, Kleemann T, Brachmann J, Fischer S, Birkenhauer F, Eberhardt F. Reduction of inappropriate ICD therapies in patients with primary prevention of sudden cardiac death: DECREASE study. Clin Res Cardiol. 2015; 104: 1021 â 1032.
dc.identifier.citedreferenceMoss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M; for the Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996; 335: 1933 â 1940.
dc.identifier.citedreferenceMoss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML; for the Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002; 346: 877 â 883.
dc.identifier.citedreferenceBardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clappâ Channing N, Davidsonâ Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; for the Sudden Cardiac Death in Heart Failure Trial (SCDâ HeFT) Investigators. Amiodarone or an implantable cardioverterâ defibrillator for congestive heart failure. N Engl J Med. 2005; 352: 225 â 237.
dc.identifier.citedreferenceBhavnani SP, Giedrimeiene D, Coleman CI, Guertin D, Azeem M, Kluger J. The healthcare utilization and cost of treating patients experiencing inappropriate implantable cardioverter defibrillator shocks: a propensity score study. Pacing Clin Electrophysiol. 2014; 37: 1315 â 1323.
dc.identifier.citedreferencePoole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008; 359: 1009 â 1017.
dc.identifier.citedreferenceMark DB, Anstrom KJ, Sun JL, Clappâ Channing NE, Tsiatis AA, Davidsonâ Ray L, Lee KL, Bardy GH; for the Sudden Cardiac Death in Heart Failure Trial Investigators. Quality of life with defibrillator therapy or amiodarone in heart failure. N Engl J Med. 2008; 359: 999 â 1008.
dc.identifier.citedreferenceFogel RI, Epstein AE, Estes NAM, Lindsay BD, DiMarco JP, Kremers MS, Kapa S, Brindis RG, Russo AM. The disconnect between the guidelines, the appropriate use criteria, and reimbursement coverage decisions: the ultimate dilemma. J Am Coll Cardiol. 2014; 63: 12 â 14.
dc.identifier.citedreferenceKremers MS, Hammill SC, Berul CI, Koutras C, Curtis JS, Wang Y, Beachy J, Meisnere LB, Conyers DM, Reynolds MR, Heidenreich PA, Alâ Khatib SM, Pina IL, Blake K, Walsh MN, Wilkoff BL, Shalaby A, Masoudi FA, Rumsfeld J. The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011. Heart Rhythm. 2013; 10: e59 â e65.
dc.identifier.citedreferenceMasoudi FA, Havranek EP, Wolfe P, Gross CP, Rathore SS, Steiner JF, Ordin DL, Krumholz HM. Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure. Am Heart J. 2003; 146: 250 â 257.
dc.identifier.citedreferenceSharma PP, Greenlee RT, Anderson KP, Chyou PH, Osorio HJ, Smith PN, Hayes JH, Vidaillet H. Prevalence and mortality of patients with myocardial infarction and reduced left ventricular ejection fraction in a defined community: relation to the second multicenter automatic defibrillator implantation trial. J Interv Card Electrophysiol. 2007; 19: 157 â 164.
dc.identifier.citedreferenceCenters for Medicare and Medicaid Services. Decision memo for implantable defibrillators (CAGâ 00157R3). 2005. Available at: https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=148. Accessed March 15, 2018.
dc.identifier.citedreferenceHammill SC, Kremers MS, Stevenson LW, Heidenreich PA, Lang CM, Curtis JP, Wang Y, Berul CI, Kadish AH, Alâ Khatib SM, Pina IL, Walsh MN, Mirro MJ, Lindsay BD, Reynolds MR, Pontzer K, Blum L, Masoudi F, Rumsfeld J, Brindis RG. Review of the registry’s fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure. Heart Rhythm. 2010; 7: 1340 â 1345.
dc.identifier.citedreferenceMasoudi FA, Go AS, Magid DJ, Cassidyâ Bushrow AE, Doris JM, Fiocci F, Garciaâ Montilla R, Glenn KA, Goldberg RJ, Gupta N, Gurwitz JH, Hammill SC, Hayes JJ, Jackson N, Kadish A, Lauer M, Miller AW, Multerer D, Peterson PN, Reifler LM, Reynolds K, Saczynski JS, Schuger C, Sharma PP, Smith DH, Suits M, Sung SH, Varosy PD, Vidaillet HJ, Greenlee RT. Longitudinal study of implantable cardioverterâ defibrillators: methods and clinical characteristics of patients receiving implantable cardioverterâ defibrillators for primary prevention in contemporary practice. Circ Cardiovasc Qual Outcomes. 2012; 5: e78 â e85.
dc.identifier.citedreferenceGo AS, Magid DJ, Wells B, Sung SH, Cassidyâ Bushrow AE, Greenlee RT, Langer RD, Lieu TA, Margolis KL, Masoudi FA, McNeal CJ, Murata GH, Newton KM, Novotny R, Reynolds K, Roblin DW, Smith DH, Vupputuri S, White RE, Olson J, Rumsfeld JS, Gurwitz JH. The Cardiovascular Research Network (CVRN): a new paradigm for cardiovascular quality and outcomes research. Circ Cardiovasc Qual Outcomes. 2008; 1: 138 â 147.
dc.identifier.citedreferenceRoss TR, Ng D, Brown JS, Pardee R. The HMO Research Network Virtual Data Warehouse: a public data model to support collaboration. EGEMS (Wash DC). 2014; 2: 1049. DOI: 10.13063/2327â 9214.1049.
dc.identifier.citedreferenceCredner SC, Klingenheben T, Mauss O, Sticherling C, Hohnloser SH. Electrical storm in patients with transvenous implantable cardioverterâ defibrillators: incidence, management and prognostic implications. J Am Coll Cardiol. 1998; 32: 1909 â 1915.
dc.identifier.citedreferenceBelsley DA. Conditioning Diagnostics: Collinearity and Weak Data in Regression. New York: Wiley Interscience; 1991.
dc.identifier.citedreferenceHarrell FE Jr. Regression Modeling Strategies With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York, NY: Springerâ Verlag, New York, Inc; 2001.
dc.identifier.citedreferenceLash TL, Fox MP, Fink AK. Applying Quantitative Bias Analysis to Epidemiologic Data. New York: Springer Science & Business Media; 2011.
dc.identifier.citedreferenceAlâ Khatib SM, Gierisch JM, Crowley MJ, Coeytaux RR, Myers ER, Kendrick A, Sanders GD. Future research prioritization: implantable cardioverterâ defibrillator therapy in older patients. J Gen Intern Med. 2015; 30: 1812 â 1820.
dc.identifier.citedreferenceMoss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, Daubert JP, McNitt S, Andrews ML, Elkin AD; for the Multicenter Automatic Defibrillator Implantation Trialâ II (MADITâ II) Research Group. Longâ term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation. 2004; 110: 3760 â 3765.
dc.identifier.citedreferenceDaubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ; for the MADIT II Investigators. Inappropriate implantable cardioverterâ defibrillator shocks in MADITâ II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol. 2008; 51: 1357 â 1365.
dc.identifier.citedreferenceKutyifa V, Zareba W, Moss AJ. ICD programming to reduce shocks and improve outcomes. Curr Cardiol Rep. 2014; 16: 496.
dc.identifier.citedreferenceMoss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, Estes NAM, Greenberg H, Hall WJ, Huang DT, Kautzner J, Klein H, McNitt S, Olshansky B, Shoda M, Wilber D, Zareba W; for the MADITâ RIT Trial Investigators. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 2012; 367: 2275 â 2283.
dc.identifier.citedreferenceGasparini M, Proclemer A, Klersy C, Kloppe A, Lunati M, Martinez Ferrer JB, Hersi A, Gulaj M, Wijfels MCEF, Santi E, Manotta L, Arenal A. Effect of longâ detection interval vs standardâ detection interval for implantable cardioverterâ defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial. JAMA. 2013; 309: 1903 â 1911.
dc.identifier.citedreferenceSaeed M, Hanna I, Dionyssios R, Styperek R, Polosajian L, Khan A, Alonso J, Nabutovsky Y, Neason C. Programming implantable cardioverterâ defibrillators in patients with primary prevention indication to prolong time to first shock: results from the PROVIDE study. J Cardiovasc Electrophysiol. 2014; 25: 52 â 59.
dc.identifier.citedreferenceWilkoff BL, Ousdigian KT, Sterns LD, Wang ZJ, Wilson RD, Morgan JM; for the EMPIRIC Trial Investigators. A comparison of empiric to physicianâ tailored programming of implantable cardioverter defibrillators: results from the prospective randomized multicenter EMPIRIC trial. J Am Coll Cardiol. 2006; 48: 330 â 339.
dc.identifier.citedreferenceWilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, Birgersdotterâ Green UM, Wathen MS, Van Gelder IC, Heubner BM, Brown ML, Holloman KK; for the PREPARE Study Investigators. Strategic programming of detection and therapy parameters in implantable cardioverterâ defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol. 2008; 52: 541 â 550.
dc.identifier.citedreferenceCheng A, Zhang Y, Blascoâ Colmenares E, Dalal D, Butcher B, Norgard S, Eldadah Z, Ellenbogen KA, Dickfeld T, Spragg DD, Marine JE, Guallar E, Tomaselli GF. Protein biomarkers identify patients unlikely to benefit from primary prevention ICDs: findings from the PROSEâ ICD study. Circ Arrhythm Electrophysiol. 2014; 7: 1084 â 1091.
dc.identifier.citedreferenceLee DS, Hardy J, Yee R, Healey JS, Birnie D, Simpson CS, Crystal E, Mangat I, Nanthakuma K, Wang X, Krahn AD, Dorian P, Austin PC, Tu JV; on behalf of the Investigators of the Ontario ICD Database. Clinical risk stratification for primary prevention implantable cardioverter defibrillators. Circ Heart Fail. 2015; 8: 927 â 937.
dc.identifier.citedreferenceWeeke P, Johansen JB, Jørgensen OD, Nielsen JC, Moller M, Videbaek R, Hojgaard MV, Riahi S, Jacobsen PK. Mortality and appropriate and inappropriate therapy in patients with ischaemic heart disease and implanted cardioverterâ defibrillators for primary prevention: data from the Danish ICD Register. Europace. 2013; 15: 1150 â 1157.
dc.identifier.citedreferenceSweeney MO, Sakaguchi S, Simons G, Machado C, Connett JE, Yang F; for the OMNI Study Investigators. Response to the Center for Medicare & Medicaid Services coverage with evidence development request for primary prevention implantable cardioverter defibrillators: data from the OMNI study. Heart Rhythm. 2012; 9: 1058 â 1066.
dc.identifier.citedreferenceSingh JP, Hall WJ, McNitt S, Wang H, Daubert JP, Zareba W, Ruskin JN, Moss AJ; the MADITâ II Investigators. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADITâ II). J Am Coll Cardiol. 2005; 46: 1712 â 1720.
dc.identifier.citedreferenceBhavnani SP, Pavuluri V, Coleman CI, Guertin D, Yarlagadda RK, Clyne CA, Kluger J. The genderâ paradox among patients with implantable cardioverterâ defibrillators: a propensityâ matched study. Pacing Clin Electrophysiol. 2013; 36: 878 â 884.
dc.identifier.citedreferenceMacFadden DR, Crystal E, Krahn AD, Mangat I, Healey JS, Dorian P, Birnie D, Simpson CS, Khaykin Y, Pinter A, Nanthakumar K, Clzavara AJ, Austin PC, Tu JV, Lee DS. Sex differences in implantable cardioverterâ defibrillator outcomes: findings from a prospective defibrillator database. Ann Intern Med. 2012; 156: 195 â 203.
dc.identifier.citedreferenceRusso AM, Poole JE, Mark DB, Anderson J, Hellkamp AS, Lee KL, Johnson GW, Domanski M, Bardy GH; for the SCDâ HeFT Investigators. Primary prevention with defibrillator therapy in women: results from the sudden cardiac death in heart failure trial. J Cardiovasc Electrophysiol. 2008; 19: 720 â 724.
dc.identifier.citedreferencevan Rees JB, Borleffs CJW, de Bie MK, Stijnen T, van Erven L, Bax JJ, Schalij MJ. Inappropriate implantable cardioverterâ defibrillator shocks: incidence, predictors, and impact on mortality. J Am Coll Cardiol. 2011; 57: 556 â 562.
dc.identifier.citedreferenceKutyifa V, Daubert JP, Olshansky B, Huang DT, Zhang C, Ruwald ACH, McNitt S, Zareba W, Moss AJ, Schuger C. Characterization and predictors of first and subsequent inappropriate ICD therapy by heart rate ranges: result of the MADITâ RIT efficacy analysis. Heart Rhythm. 2015; 12: 2030 â 2037.
dc.identifier.citedreferencePokorney SD, Hellkamp AS, Yancy CW, Curtis LH, Hammill SC, Peterson ED, Masoudi FA, Bhatt DL, Alâ Khalidi HR, Heidenreich PA, Anstrom KJ, Fonarow GC, Alâ Khatib SM. Primary prevention implantable cardioverterâ defibrillators in older racial and ethnic minority patients. Circ Arrhythm Electrophysiol. 2015; 8: 145 â 151.
dc.identifier.citedreferenceBigger JT Jr, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM; the Multicenter Postâ Infarction Research Group. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation. 1984; 69: 250 â 258.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
jah33061_am.pdf
Size:
264.3KB
Format:
PDF
View/Open
Name:
jah33061.pdf
Size:
559.6KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.